miR-223-3p repression led to increased expression of tumor supportive cytokines VEGF and IL6 and inhibition of the osteogenic potential of MM-MSCs, as indicated by reduced expression of RUNX2 and OPN, as well as reduced calcification and ALPL activity [89]. The gene discussed is IL6; the disease is Miyoshi myopathy.